Evidence map›Paper›PMID 34680727›Full record

ArticleAntibiotics (Basel, Switzerland)2021

The Impact of COVID-19 on the Profile of Hospital-Acquired Infections in Adult Intensive Care Units.

Aleksa Despotovic, Branko Milosevic, Andja Cirkovic, Ankica Vujovic, Ksenija Cucanic, Teodora Cucanic, Goran Stevanovic

Open access · goldAbstract read
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed, 2 pooled it
5.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 2 syntheses or guidelines pooled it, 51 citations in OpenAlex.

  1. Antibiotic resistance associated with the COVID-19 pandemic: a systematic review and meta-analysis.Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases · 2023
    Pooled it
  2. Antibiotic Resistance during COVID-19: A Systematic Review.International journal of environmental research and public health · 2022
    Pooled it
  3. Article
  4. Enhanced Spread of Carbapenem-ResistantInfection and drug resistance · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Exploring the evolution ofAntimicrobial stewardship & healthcare epidemiology : ASHE · 2025
    Article
  10. Article
  11. Article
  12. Carbapenem-ResistantAntibiotics (Basel, Switzerland) · 2024
    Review
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Carbapenem-ResistantAntibiotics (Basel, Switzerland) · 2023
    Article
  19. Antimicrobial Resistance inMicroorganisms · 2023
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Aleksa DespotovicFaculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia.ORCID 0000-0001-8137-911X
Branko MilosevicFaculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia.
Andja CirkovicDepartment of Medical Statistics, Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia.
Ankica VujovicFaculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia.ORCID 0000-0001-9570-215X
Ksenija CucanicTeaching Hospital for Infectious and Tropical Diseases, University Clinical Center of Serbia, 11000 Belgrade, Serbia.ORCID 0000-0002-1442-4897
Teodora CucanicTeaching Hospital for Infectious and Tropical Diseases, University Clinical Center of Serbia, 11000 Belgrade, Serbia.ORCID 0000-0003-4851-8645
Goran StevanovicFaculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia.
University of Belgrade · RSUniversity Children's Hospital, Belgrade · RS

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hospital-acquired infections (HAIs) are a global public health concern. As the COVID-19 pandemic continues, its contribution to mortality and antimicrobial resistance (AMR) grows, particularly in intensive care units (ICUs). A two-year retrospective study from April 2019-April 2021 was conducted in an adult ICU at the Hospital for Infectious and Tropical Diseases, Belgrade, Serbia to assess causative agents of HAIs and AMR rates, with the COVID-19 pandemic ensuing halfway through the study. Resistance rates >80% were observed for the majority of tested antimicrobials. In COVID-19 patients,

Indexed as

adultsantimicrobial resistancecarbapenem resistanceCOVID-19empiric therapyhospital-acquired infectionsintensive care unitSerbiasurveillancetrend analysis

Identifiers

PMID34680727
PMCPMC8532680
OpenAlexW3199767845

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.